惯性聚合 高效追踪和阅读你感兴趣的博客、新闻、科技资讯
阅读原文 在惯性聚合中打开

推荐订阅源

爱范儿
爱范儿
T
The Blog of Author Tim Ferriss
G
Google Developers Blog
博
博客园_首页
博
博客园 - 【当耐特】
量
量子位
S
SegmentFault 最新的问题
B
Blog RSS Feed
酷 壳 – CoolShell
酷 壳 – CoolShell
V
Visual Studio Blog
T
Tailwind CSS Blog
阮一峰的网络日志
阮一峰的网络日志
V
V2EX
Y
Y Combinator Blog
博
博客园 - 聂微东
The Cloudflare Blog
小众软件
小众软件
J
Java Code Geeks
freeCodeCamp Programming Tutorials: Python, JavaScript, Git & More
月光博客
月光博客
H
Help Net Security
Jina AI
Jina AI
钛媒体：引领未来商业与生活新知
钛媒体：引领未来商业与生活新知
宝玉的分享
宝玉的分享

All Articles on Seeking Alpha

All Eyes On Cencora, A Healthcare Supplier That Could See Lots More Upside Simply Good Foods Doesn't Look Like A Growth Stock Anymore Applied Digital: Post-Earnings Clarity Confirms An Accelerated Path To $1 Billion NOI Target IBIT: Why I Stepped To The Side (Technical Analysis) (Rating Downgrade) XES: Oil Service Stocks Turn Pricey; Why It's Time To Take Profits (Rating Downgrade) The Only Dividend Strategy I'd Trust In A 3.5% Fed Funds World Opera: AI-Driven Advertising Prospects - Upside Potential And Rich Dividend Yields RenaissanceRe: Preferred Stock Hasn't Been This Appealing In Years Q1 Earnings Kick Off With Major Banks' Results: Bank of America, Netflix In Focus Sezzle: Consolidation Completed, Re-Rating Ahead Bitmine Immersion Q2 Preview: Ethereum Thesis Facing Important Report Card I Am Sharing 2 Of My Retirement High-Yield Gems The Software Narrative Is Leaking Badly Again Thanks To Anthropic Mythos The Muni Market Looks Appealing In Q2 AVIV: Should Keep Rising If The Ceasefire Holds Foundayo Explained: Lilly's New Weight Loss Pill And The Amazon Effect Sabesp: A New Privatization As An Opportunity! EchoStar: Potential Bull Trap At Play - Take Gains Off The Table Teladoc Health: Improving Fundamentals Support A Turnaround Story March CPI Inflation: 5 Reasons To Stay Calm Two 12%+ Yielding BDC Bargains (One Is My Top Deep-Value Pick) TechnipFMC: We Prefer Saipem With More Room To Improve Tesla: From Bye-Bye To Buy-Buy (Rating Upgrade) DMB: Vulnerable To High Interest Rates Western Midstream: A 9% Yield That Still Grows In A Downturn IQQQ: Tax-Efficient Income From The Nasdaq But Does Not Protect Against Declines Qualys Share Price Pulled Down By Potential Cybersecurity Disruptor S&P 500: A Dead Money Era May Be Here. How To Thrive In It Vistance Networks Looks Better Than Before With Powerful Earnings Growth Commerce Bancshares: Valuation, Not Quality, Is The Problem
Sartorius Stedim Biotech S.A. (SRTOY) Q1 2026 Earnings Ca...
2026-04-24 · via All Articles on Seeking Alpha

Sartorius Stedim Biotech S.A. (SRTOY) Q1 2026 Earnings Call April 23, 2026 7:00 AM EDT

Company Participants

Petra Muller - Head of Investor Relations
Michael Grosse - CEO & Chairman of the Executive Board
Florian Funck - CFO & Member of Executive Board
Rene Faber - Head of Bioprocess Solutions Division & Member of Executive Board

Conference Call Participants

Zain Ebrahim - JPMorgan Chase & Co, Research Division
Douglas Schenkel - Wolfe Research, LLC
Subhalaxmi Nambi - Guggenheim Securities, LLC, Research Division
Charles Pitman - Barclays Bank PLC, Research Division
Charlie Haywood - BofA Securities, Research Division
Charles Weston - RBC Capital Markets, Research Division
Oliver Metzger - ODDO BHF Corporate & Markets, Research Division
Odysseas Manesiotis - BNP Paribas, Research Division
Thibault Boutherin - Morgan Stanley, Research Division
James Vane-Tempest - Jefferies LLC, Research Division
Naresh Chouhan - Intron Health Advisors Ltd
Falko Friedrichs - Deutsche Bank AG, Research Division
Delphine Le Louet - Bernstein Institutional Services LLC, Research Division

Presentation

Operator

Ladies and gentlemen welcome to the Sartorius and Sartorius Stedim Biotech Conference Call and Live Webcast on Q1 2026. I'm Moritz, your Chorus Call operator. [Operator Instructions] I would now like to turn the conference over to Petra Muller, Head of Investor Relations of Sartorius. Please go ahead.

Petra Muller
Head of Investor Relations

Thank you. Hello, and a warm welcome also from my side. I'm joined today by our CEO, Michael Grosse; by Florian Funck, our CFO; Rene Faber, Head of the Bioprocessing Division and CEO of Sartorius Stedim Biotech; and by Alexandra Gatzemeyer, Head of our LPS division.

As always, we will start with prepared remarks followed by the Q&A session. [Operator Instructions]. Please note that management comments during this call will be include forward-looking statements that involve risks and uncertainties. For a discussion of risk factors, I encourage you to review the safe harbor statement contained in today's press release and the

此内容由惯性聚合(RSS阅读器)自动聚合整理，仅供阅读参考。 原文来自 — 版权归原作者所有。